Sorry for the Run-on sentences in advance. If you have any questions about my research or any data related to my blogs, just inquire about them via comment. I am a 20 year old finance student studying the pharmaceutical industry and in particular the top performing industries of Biotech and life science research. I research companies that target untapped markets and follow capital expenditure trends of the industry to capitalize on surrounding opportunities. Companies working with government funded research institutions (NIH, Foundations, Universities) are my favorite long picks. I am long small caps with strong pipelines and balance sheets, and short most one trick unicorns that don't have value or technical support. I pick my trades on a company by company basis. I don't always require that a company is involved in a favorable industry that has unmet demand by big pharma, but that is where I believe discrepancies in valuations occur most often. Recently, I have moved with momentum and enjoy testing hype in valuations. I use fundamental analysis, some historical pricing model techniques, and ultimately, macro themes to build and test my thesis's for industry analysis and trading. I always trade on technical analysis, but find value in fundamentals. In 2016, my Biotech industry top picks are involved in the clinical development of therapies in ophthalmology (Dry eye, DME, AMD), rare diseases (MF, Lupus, DMD), lung disorders (COPD), cardiovascular diseases (PAH, DCM, CLI), and breakthrough cancer therapies (so basically anything Celgene, Roche, and Novartis miss).
Expecting a lot of crowding in Melanoma (ex. ARRY) and cholesterol drugs (ex. $ESPR, $AEGR) in 2016 with multiple expected drug launches. Finally, I am excited for Biosimilars to make their debut in 2016. PAH patent expiration for $UTHR and others in 2017 and many more mAbs before 2019 should open up some serious patent cases and entrants. I am still expecting a ton of BLAs to be filed in 2016 (ex. $PFNX, $MNTA, $SRNE). Thanks for reading, tweet @Kuritzmike if you want to see what I'm trading on the day to day.
Dabbling here and there while in school working on a Computer Science degree from OSU. First degree was in Science from PSU. I enjoy the challenge investing has to offer. My main focus is on companies in the OTC market. Main sectors of interest: marijuana, robotics, biotechnology and pharm. / med. The scientist a great story about the grandfather of cannabis research Dr Mechoulam:https://www.youtube.com/watch?v=PWabJ6DS55Q (a documentary I find greatly informative and a good watch IMHO.)
iHub membership: Bluesummers (if you see snoopy in the rain and a red dog house - that's me).
OTC stocks I'm currently looking at / watching:
ELTP (anti-abuse pain medication; with ideal design behind them),
TRTC (medical / rec. marijuana products),
ASTI (solar portable products),
LMRMF (graphene supplier and manufacturer),
GPHBF (graphene 3D printing - partially owned by LMRMF), and
SFOR (key encryption software).
Non OTC stocks (mostly for capital preservation / portfolio diversification):
TWMJF (CAN marijuana),
OGI (CAN medical marijuana),
LEU (enriched uranium supplier),
SCTY (solar panels),
EBS (anthrax vaccine - only one approved by FDA),
PSTI (stromal cells for commercial use in disease treatment),
WTI (oil and gas Gulf of Mexico),
BADFF (CAN hydrovac excavation; costumer base: 51% oil and gas and 49% utility and municipality), and
BNO (oil fund).
Invested in: ELTP and LEU.
Watching: TRTC, TWMJF, GPHBF, and SFOR.
On my smartphone: